A Canadian medical cannabis retailer is seeking approval from Health Canada to conduct a clinical trial which tests the effectiveness of cannabis in treating COVID-19. Mohan Cooray, CEO of Cannalogue, a licensed online marketplace for medical cannabis products, believes that treatment with medical cannabis has the potential to decrease the severity of COVID-19 symptoms.
“We know from a medical standpoint that these active ingredients have immunomodulatory properties, meaning that they augment the immune system to make it better,” Cooray, a doctor of internal medicine, said in a statement to the Toronto Sun.
This trial comes on the heels of another COVID-19 investigation, out of Manitoba Canada, testing the effectiveness of hydroxychloroquine, an anti-Malaria drug on the virus. This is one of four drugs currently being tested by the World Health Organization for use against COVID-19.
“We’re really focusing on trying to reduce the severity of symptoms and maybe hoping to impact some of the fatalities that are happening, especially locally,” Dr. Cooray told The GrowthOp.
The highly contagious respiratory virus, commonly known as Corona Virus, has now infected almost three quarters of a million people and can be found in the majority of nations and territories across Earth. Many Canadian industries are in various stages of lockdown in attempt to reduce the spread of the virus. There is currently no vaccine for COVID-19, however researchers are hard at work to develop one.